Concepedia

Jamie Ketas

JK

6

Publications

741

Citations

6

H-Index

2003

Active since

Affiliations

Cornell University(Current)

NewYork–Presbyterian Hospital

Center for Molecular Medicine and Immunology

Presbyterian Hospital

Immunomedics (United States)

Jamie Ketas is an author at Cornell University specializing in allergy, immunology, and tumor biology.

Top concepts

Publications per year

2003–2006

6

Publications

6

Phase I/II Trial of Epratuzumab (Humanized Anti-CD22 Antibody) in Indolent Non-Hodgkin’s Lymphoma

John P. Leonard, Morton Coleman, Jamie Ketas et al. · Journal of Clinical Oncology · 2003 · 252 citations

Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma

John P. Leonard, Morton Coleman, Jamie Ketas et al. · Clinical Cancer Research · 2004 · 226 citations

Combination Antibody Therapy With Epratuzumab and Rituximab in Relapsed or Refractory Non-Hodgkin's Lymphoma

John P. Leonard, Morton Coleman, Jamie Ketas et al. · Journal of Clinical Oncology · 2005 · 163 citations · Full text

Epratuzumab: targeting B-cell malignancies through CD22.

Morton Coleman, David M. Goldenberg, Abby B. Siegel et al. · PubMed · 2003 · 47 citations

, , +15

Phase I/II Trial of Bortezomib + CHOP-Rituximab in Diffuse Large B Cell (DLBCL) and Mantle Cell Lymphoma (MCL): Phase I Results.

John P. Leonard, Richard R. Furman, Ying‐Kuen Cheung et al. · Blood · 2005 · 41 citations

Rows per page

1–5 of 6